🟢 Indaptus Therapeutics is trading 8.6% up today after announcing a roughly $24 million private placement

Indaptus Therapeutics is trading 8.6% up now at $2.78 after its September 10, 2026 announcement of a roughly $24 million private placement.

• The financing covers approximately 20.3 million shares and is intended for working capital, research and development, and general corporate purposes, including potential sleep-related neurotechnology research.
• Shares closed September 10, 2026 at $2.56, up 23.08%.
• Broader markets are higher, but the private placement better explains the company’s outsized advance.